Enabling precision oncotherapy

Clinical trial success rate is particularly low in oncology, and we want to improve that.
By capturing the complexity of the human tumor microenvironment, we create models that better predict how tumors respond to therapy.
Our 3D in vitro platforms enable precise evaluation of drug effects across multiple cancer phenotypes.

Want to know how we do it?
×